These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7673609)

  • 1. Lansoprazole versus famotidine in symptomatic reflux esophagitis: a randomized, multicenter study.
    Umeda N; Miki K; Hoshino E
    J Clin Gastroenterol; 1995; 20 Suppl 1():S17-23. PubMed ID: 7673609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of symptoms in step-down therapy of gastroesophageal reflux disease.
    Mine S; Iida T; Tabata T; Kishikawa H; Tanaka Y
    J Gastroenterol Hepatol; 2005 Sep; 20(9):1365-70. PubMed ID: 16105122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symptom relief in patients with reflux esophagitis: comparative study of omeprazole, lansoprazole, and rabeprazole.
    Adachi K; Hashimoto T; Hamamoto N; Hirakawa K; Niigaki M; Miyake T; Taniura H; Ono M; Kaji T; Suetsugu H; Yagi J; Komazawa Y; Mihara T; Katsube T; Fujishiro H; Shizuku T; Hattori S; Yamamoto S; Kinoshita Y
    J Gastroenterol Hepatol; 2003 Dec; 18(12):1392-8. PubMed ID: 14675268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pantoprazole versus lansoprazole in French patients with reflux esophagitis.
    Dupas JL; Houcke P; Samoyeau R;
    Gastroenterol Clin Biol; 2001 Mar; 25(3):245-50. PubMed ID: 11395670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a proton pump inhibitor, AG-1749 (lansoprazole), on reflux esophagitis and experimental ulcers in rats.
    Inatomi N; Nagaya H; Takami K; Shino A; Satoh H
    Jpn J Pharmacol; 1991 Apr; 55(4):437-51. PubMed ID: 1886289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis.
    Castell DO; Kahrilas PJ; Richter JE; Vakil NB; Johnson DA; Zuckerman S; Skammer W; Levine JG
    Am J Gastroenterol; 2002 Mar; 97(3):575-83. PubMed ID: 11922549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
    Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
    Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing lansoprazole and omeprazole in onset of heartburn relief: results of a randomized, controlled trial in erosive esophagitis patients.
    Richter JE; Kahrilas PJ; Sontag SJ; Kovacs TO; Huang B; Pencyla JL
    Am J Gastroenterol; 2001 Nov; 96(11):3089-98. PubMed ID: 11721754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lansoprazole versus omeprazole in the treatment of reflux esophagitis.
    Vcev A; Stimac D; Vceva A; Rubinić M; Ivandić A; Ivanis N; Horvat D; Volarić M; Karner I
    Acta Med Croatica; 1997; 51(3):171-4. PubMed ID: 9248117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasonographic evaluation of lansoprazole-induced improvement of submucosal injury in patients with gastroesophageal reflux.
    Mine S; Fujisaki T; Tabata T; Matsuoka H; Iida T; Yamada S; Tanaka Y; Morimoto I; Eto S; Aibe T
    Am J Gastroenterol; 2000 Feb; 95(2):381-6. PubMed ID: 10685739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of lansoprazole in adolescents with symptomatic erosive and non-erosive gastroesophageal reflux disease.
    Fiedorek S; Tolia V; Gold BD; Huang B; Stolle J; Lee C; Gremse D
    J Pediatr Gastroenterol Nutr; 2005 Mar; 40(3):319-27. PubMed ID: 15735486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long-term maintenance treatment of reflux esophagitis resistant to H2-RA with PPI (lansoprazole)].
    Endo M; Sugihara K
    Nihon Rinsho; 2000 Sep; 58(9):1865-70. PubMed ID: 11004817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lansoprazole in the treatment of reflux oesophagitis: a survey of clinical studies.
    Berstad A; Hatlebakk JG
    Aliment Pharmacol Ther; 1993; 7 Suppl 1():34-6, discussion 61-6. PubMed ID: 8490077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lansoprazole compared with ranitidine for the treatment of nonerosive gastroesophageal reflux disease.
    Richter JE; Campbell DR; Kahrilas PJ; Huang B; Fludas C
    Arch Intern Med; 2000 Jun; 160(12):1803-9. PubMed ID: 10871974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of lansoprazole and famotidine for gastric ulcer by endoscopic ultrasonography: a preliminary trial.
    Okai T; Sawabu N; Songür Y; Motoo Y; Watanabe H
    J Clin Gastroenterol; 1995; 20 Suppl 2():S32-5. PubMed ID: 7594335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer.
    Poynard T; Lemaire M; Agostini H
    Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):661-5. PubMed ID: 8590162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lansoprazole versus famotidine: efficacy and tolerance in the acute management of duodenal ulceration.
    Hotz J; Kleinert R; Grymbowski T; Hennig U; Schwarz JA
    Aliment Pharmacol Ther; 1992 Feb; 6(1):87-95. PubMed ID: 1543819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressive action of lansoprazole on gastric acidity and its clinical effect in patients with gastric ulcers: comparison with famotidine.
    Sakaguchi M; Ashida K; Umegaki E; Miyoshi H; Katsu K
    J Clin Gastroenterol; 1995; 20 Suppl 2():S27-31. PubMed ID: 7594334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of omeprazole and famotidine in treatment of upper abdominal symptoms in patients with reflux esophagitis.
    Kusunoki H; Kusaka M; Kido S; Yamauchi R; Fujimura Y; Watanabe Y; Kobori M; Miwa H; Tomita T; Kin Y; Hori K; Tano N; Sugimoto K; Nakamura Y; Fujimoto K; Oza N; Matsunobu A; Ono N; Fuyuno S; Kinoshita Y; Adachi K; Yuki M; Fujisawa T; Haruma K
    J Gastroenterol; 2009; 44(4):261-70. PubMed ID: 19280112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of reflux esophagitis resistant to H2-receptor antagonists with lansoprazole, a new H+/K(+)-ATPase inhibitor: a controlled, double-blind study. Lansoprazole Study Group.
    Feldman M; Harford WV; Fisher RS; Sampliner RE; Murray SB; Greski-Rose PA; Jennings DE
    Am J Gastroenterol; 1993 Aug; 88(8):1212-7. PubMed ID: 8101695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.